Focus
immunocompromised
Immunosuppression Prevalence Doubled, Linked to Medication Use and COVID: Experts
In 2021, an estimated 6.6 percent of U.S. adults were immunosuppressed. The estimate was 2.7 percent in 2013.
Frequent COVID Boosters in Immunocompromised ‘May Be Causing More Harm Than Benefit,’ New Review Suggests
Repeated mRNA COVID-19 vaccination impairs the activation of immune cells that protect the body from infections and cancer.
The Immunocompromised Recover From COVID-19 More Quickly Than Expected: Study
One study shows that even the most vulnerable populations can clear the COVID-19 virus within a couple weeks rather than several months.
Stem Cell Gene Therapy Trial for Children Launches in Australia
Genetically modified stem cells will be injected into the child’s bloodstream to build a new functional immune system, researchers say.
